Editorials

Management of head and neck cancer in Britain

BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7122.1556 (Published 13 December 1997) Cite this as: BMJ 1997;315:1556

Plenty of room for improvement

  1. J S Tobias, President, British Association of Head and Neck Oncologists, and consultant in radiotherapy and oncologya
  1. a Meyerstein Institute of Oncology, Middlesex Hospital, London W1N 8AA

    Surgical and radiation oncologists will readily disagree over many aspects of cancer management but one point is widely accepted: patients with head and neck cancer probably present the greatest challenge of all. Apart from the obvious difficulty of assessing a range of treatment strategies for an unusually wide number of primary sites (larynx, pharynx, oral cavity, paranasal sinuses, etc)and the consequent difficulty in comparing outcomes, so many patients have to face devastating treatment consequences as the price of cure. What is more, although the incidence of head and neck cancer is rising,1 the relatively small number of patients—fewer than 5000 new cases a year in Britain—has slowed cooperative efforts in building worthwhile databases or, better still, mounting prospective clinical studies large enough to provide meaningful results.

    The brief report by Edwards and colleagues in this week's issue provides a disturbing overview of current provision for the treatment of head and neck cancer in Britain (p 1589 …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe